Skip to main content

Saturation biopsies of the prostate, extensive transperineal sampling for men with persistently rising PSA and negative prior biopsy.

Saturation biopsy of the prostate is an extensive transperineal biopsy technique - 30-40+ cores under general anaesthetic - for men with persistently rising PSA and prior negative TRUS biopsies, or for detailed cancer mapping before focal therapy.

A consultant urological surgeon reviewing prostate MRI before a transperineal saturation biopsy in a private London clinic

Key facts

  • 01

    Extensive transperineal biopsy

    A saturation biopsy is an extensive transperineal prostate sampling technique - not a routine TRUS.

  • 02

    General anaesthetic day-case

    Performed under general anaesthetic as a day-case procedure in a private theatre.

  • 03

    30–40+ cores

    Systematic template sampling of 30–40+ cores across the entire gland, mapped to sector.

  • 04

    Higher detection than TRUS

    Detects significant prostate cancer missed by prior transrectal (TRUS) biopsy.

  • 05

    Foundation for focal therapy

    Provides the per-sector map that focal HIFU or cryotherapy planning depends on.

  • 06

    Complements mpMRI

    Correlates every sector against multiparametric MRI - imaging and pathology together.

The problem

A negative TRUS biopsy isn’t always the answer.

Standard transrectal biopsy systematically undersamples the anterior and apical prostate. When PSA keeps rising after a negative TRUS, or when focal therapy is on the table, the answer is a full transperineal saturation map - not another round of the same test.

  • Planning focal therapy?

    The per-sector map is the foundation focal HIFU or cryotherapy planning depends on.

  • Discordant mpMRI?

    A PI-RADS 4/5 lesion with a negative sector needs re-read and template resampling.

The diagnostic pathway

From consultation to MDT plan - what happens, in order.

One consultant urologist from first message to plan, with the multi-disciplinary team behind every decision.

  1. 01

    Before

    Urology consultation

    Consultant urologist reviews PSA trend, prior biopsies, symptoms, family history and comorbidity.

  2. 02

    Before

    mpMRI review

    Multiparametric prostate MRI is re-read against PI-RADS and mapped to sectors before theatre.

  3. 03

    Before

    General anaesthetic assessment

    Pre-operative anaesthetic review - fitness, medication, day-case planning.

  4. 04

    Theatre

    Transperineal saturation biopsy

    30–40+ template cores taken through the perineum under general anaesthetic - no rectal entry.

  5. 05

    After

    Pathology per core

    Uropathology reports each core individually - Gleason grade, ISUP group, cancer length.

  6. 06

    After

    MDT review

    Uro-oncology multi-disciplinary team combines imaging, pathology and clinical picture.

  7. 07

    After

    Structured plan

    A written plan - surveillance, focal therapy, radical treatment or observation - with next steps.

Typical end-to-end: 2–3 weeks. Urgent cases: 7–10 days.

What it shows

What the sector-by-sector map reveals.

A saturation biopsy answers questions a TRUS cannot - where the disease is, how much of it there is, and whether the gland is a candidate for focal therapy.

  • Per-core Gleason grade

    Every core reported individually with Gleason score and ISUP grade group.

  • Per-core cancer length

    Millimetre length of cancer in each core - a key driver of significance.

  • Anterior tumour detection

    Reaches anterior and apical zones that transrectal biopsy systematically undersamples.

  • Bilateral disease pattern

    Maps whether disease is unilateral, bilateral, unifocal or multifocal.

  • Tumour volume estimation

    Approximates disease burden - foundation for treatment intensity decisions.

  • Radiological–pathological concordance

    Correlates mpMRI PI-RADS lesions against the histology of each sector.

  • Suitability for focal therapy

    The sector map is what focal HIFU, cryotherapy or electroporation planning is built on.

  • Red flag: unexpected Gleason 8+ - urgent MDT

    Any core with Gleason 8+ triggers urgent multi-disciplinary team review the same week.

Treatment options

What the biopsy result opens up.

The saturation map defines the treatment shortlist. The MDT chooses - not the biopsy alone.

  • Active surveillance

    For low-grade unifocal disease - structured PSA, mpMRI and repeat biopsy protocol rather than immediate treatment.

  • Focal HIFU / cryotherapy

    Targeted ablation of a mapped tumour focus - organ-sparing, with continence and potency largely preserved.

  • Radical prostatectomy

    Robot-assisted removal of the prostate - for organ-confined disease where cure is the goal.

  • External beam radiotherapy

    Image-guided IMRT or SBRT - an alternative to surgery for organ-confined disease.

  • Brachytherapy

    Low-dose-rate seeds or high-dose-rate temporary implants - selected localised disease.

  • Androgen deprivation therapy

    Hormonal treatment, alone or alongside radiotherapy, in higher-risk or advanced disease.

  • Structured urology + oncology follow-up

    Combined follow-up pathway with PSA, imaging and clinical review on a defined cadence.

  • Multi-disciplinary team review

    Every plan is set by urology, oncology, radiology and pathology together - never a single voice.

Red flags

When to call, when to go to A&E.

A saturation biopsy is a well-tolerated day-case, but there are specific findings and post-procedure symptoms that change the timeline.

  • Unexpected Gleason 8+

    High-grade histology on any core triggers urgent MDT and staging within the week.

  • Bilateral high-volume disease

    Extensive disease in both lobes usually redirects the plan away from focal therapy.

  • Extraprostatic extension

    Disease breaching the prostate capsule on imaging or histology changes treatment intent.

  • Post-biopsy sepsis

    Fever, rigors or systemic symptoms after biopsy - same-day A&E, not the private clinic.

  • Post-biopsy urinary retention

    Inability to pass urine after biopsy - same-day catheterisation via A&E or the operating team.

  • Post-biopsy rectal injury

    Rare in transperineal biopsy - any significant rectal bleeding needs urgent review.

  • Anaesthetic complication

    Any post-anaesthetic concern - chest pain, breathlessness, prolonged drowsiness - is a 999 call.

  • Rising PSA post-biopsy

    A rising PSA on surveillance after a negative saturation biopsy warrants re-imaging and MDT discussion.

  • Discordant mpMRI–pathology

    A PI-RADS 4/5 lesion with a negative sector needs re-read, not reassurance.

Reading your report

A saturation biopsy report can look intimidating. It isn’t.

Whatever the finding, the pathology report keeps to the same four parts.

A consultant uro-pathologist reviewing per-core prostate biopsy slides on a clinical workstation at a UK private clinic

A quiet reminder

The report is written for the MDT, not for you - and that’s normal.

If you would like it talked through before your follow-up, ask your urologist.

  1. 01 Header

    Indication and prior investigations

    Your details, PSA trend, prior TRUS results and the mpMRI referenced for the case.

  2. 02 Technique

    Template, cores and anaesthetic

    Which template was used, how many cores were taken, and the anaesthetic and antibiotic protocol.

  3. 03 Findings

    Per-core Gleason, length and sector

    Each core reported individually - Gleason score, ISUP grade, cancer length and sector location.

  4. 04 Impression

    The MDT-ready summary: read this first

    Overall grade group, laterality, imaging concordance and the concrete next step - read this first.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Frequently asked

Common questions about saturation biopsy.

Quick answers on how it differs from TRUS, who needs it, the risks, recovery, and what happens if cancer is found.

  • What is a saturation biopsy of the prostate?

    A saturation biopsy is an extensive transperineal prostate biopsy - typically 30 to 40 or more cores taken through the perineum under general anaesthetic, using a systematic template that samples the entire gland including anterior and apical zones that transrectal biopsy tends to miss.

  • Who needs a saturation biopsy?

    It is used for men with a persistently rising PSA and one or more prior negative TRUS biopsies, and for detailed cancer mapping before focal therapy such as HIFU or cryotherapy. Your urologist and the multi-disciplinary team decide, alongside your mpMRI.

  • How is it different from a standard TRUS biopsy?

    A standard TRUS biopsy is done through the rectum, takes 10–12 cores, and is performed under local anaesthetic. A saturation biopsy is done through the perineum, takes 30–40+ cores on a systematic template, and requires general anaesthetic - with higher cancer detection and near-zero sepsis risk.

  • What are the risks?

    The main risks are urinary retention, perineal bruising, transient haematuria and haematospermia, and the general risks of anaesthesia. Sepsis is very uncommon because the biopsy avoids the rectum. Rectal injury is rare.

  • How long is recovery?

    A day-case procedure. Most men go home the same afternoon and are back to office work within 2–3 days. Blood in the semen can persist for several weeks and is expected - not a complication.

  • What happens if cancer is found?

    Your case goes to the uro-oncology multi-disciplinary team. The written plan sets out options - active surveillance, focal therapy, radical prostatectomy, radiotherapy or hormonal treatment - chosen for your grade, volume, imaging and preferences.

Sources

Guidelines this guide is built on.

Last reviewed 2026-07-30 · Next review 2027-07-30 · 6 min read

Related tests

Looking for a different test?

In practice, in London

How saturation biopsies prostate tends to unfold when you go private

With saturation biopsies prostate, the London question is usually about report turnaround and the radiologist reading it - not whether the scan is available. The NHS route for saturation biopsies prostate is thorough, but the queue is real. Many patients are told to expect anywhere from a handful of weeks to several months, depending on their local trust and how the referral is graded. Going private in London usually collapses that window to a matter of days - often the same week if the diary allows. It isn’t about jumping a queue so much as buying time back while you still have the flexibility to plan around it.

In practice, a private saturation biopsies prostate appointment in London means a named consultant, a proper hour in the room (or the equivalent on a video call), and a report you can actually read. Many of London’s private imaging suites and clinics sit around Harley Street, Chelsea and Fulham, and turnaround on findings is often measured in days, not weeks. For saturation biopsies prostate specifically, the difference between a routine report and a sub-speciality read is where private care earns its keep.

The value is knowing which consultant reads this particular presentation best, which unit turns reports around fastest, and which pathway won’t hit a dead end if the findings point somewhere unexpected.